Compounds > 4-(carboethoxyphenyl)retinamide

4-(carboethoxyphenyl)retinamide and Chemical-and-Drug-Induced-Liver-Injury

4-(carboethoxyphenyl)retinamide has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 1 studies

Other Studies

1 other study(ies) available for 4-(carboethoxyphenyl)retinamide and Chemical-and-Drug-Induced-Liver-Injury

Article	Year
Fatal Hepatotoxicity Due to Viaminate. The American journal of the medical sciences, 2018, Volume: 356, Issue:1 Viaminate is a derivative of retinoic acid (tretinoin) used in the treatment of severe acne and other disorders of keratinization. Liver dysfunction due to viaminate therapy has not been well described and there have been no reported deaths due to viaminate-induced hepatotoxicity. Herein, we report the case of a woman who underwent treatment at the hospital for 38 days and died of hepatic failure after taking viaminate for more than 2 months. This case provides further insight into viaminate-induced hepatotoxicity. Topics: Adult; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Humans; Tretinoin	2018

Article

Year

The American journal of the medical sciences, 2018, Volume: 356, Issue:1

Viaminate is a derivative of retinoic acid (tretinoin) used in the treatment of severe acne and other disorders of keratinization. Liver dysfunction due to viaminate therapy has not been well described and there have been no reported deaths due to viaminate-induced hepatotoxicity. Herein, we report the case of a woman who underwent treatment at the hospital for 38 days and died of hepatic failure after taking viaminate for more than 2 months. This case provides further insight into viaminate-induced hepatotoxicity.

Topics: Adult; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Humans; Tretinoin

2018